Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPEED: Moxifloxacin in Acute Bacterial Maxillary Sinusitis
NCT00668304Phase 4Completed
- Sponsor
- Bayer
- Start
- Jun 2004
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of moxifloxacin in Acute Bacterial Maxillary Sinusitis (ABMS), sponsored by Bayer. Started Jun 2004; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Acute Bacterial Maxillary Sinusitis (ABMS)
Beyond the preview
Go deeper on NCT00668304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668304.